Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ojima

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Paraplegia|February 1, 1994
Prognosis of cervical spinal cord injury in correlation with magnetic resonance imagingT Sato, S Kokubun, K P Rijal, et al.
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|October 6, 2000
[Case-control study of risk factors for cedar pollinosis among parents of 3-year-old children]I Oki, S Tanihara, T Ojima, et al.
Archives of Virology|November 23, 2006
Analysis of hepatitis B surface antigen mutations in Mongolia: molecular epidemiology and implications for mass vaccinationD Davaalkham, T Ojima, R Uehara, et al.
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|January 22, 1998
[Development of index of social activities for the elderly]S Hashimoto, R Aoki, A Tamakoshi, et al.
Leukemia Research|July 10, 1999
Quantification of human herpesvirus 6 in healthy volunteers and patients with lymphoproliferative disorders by PCR-ELISAJ H Ohyashiki, K Abe, T Ojima, et al.
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|September 24, 1999
[Relationship between breast milk and atopic dermatitis in children]Y Nakamura, I Oki, S Tanihara, et al.
International Journal of Molecular Medicine|September 22, 2000
Use of real-time PCR to monitor human herpesvirus 6 reactivation after allogeneic bone marrow transplantationJ H Ohyashiki, A Suzuki, K Aritaki, et al.
Bone Marrow Transplantation|December 26, 2001
A rapid monitoring system of human herpesviruses reactivation by LightCycler in stem cell transplantationK Aritaki, J H Ohyashiki, A Suzuki, et al.
Microbiology and Immunology|August 11, 2001
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assays showed a lack of toxicity of ganciclovir (GCV), C.OXTs, and their derivatives, to TaY(OK) cells at 1 microM. Therefore we compared the antiviral potencies of these drugs at 1 microM by monitoring the viral loads produced during a 1-day period during the course of the drug treatment. Among the drugs tested, 3'-fluorocarbocyclic oxetanocin A (3'F-C.OXT-A) was the most effective for inhibiting the virus production, and at concentrations ranging from 0.5 microM to 10 microM, the inhibition of the viral production was dose-dependent. A comparison of the chemical structures of the derivatives with that of C.OXT-A, which is the parental molecule, suggested that the 3'-fluorine-modification might account for the higher anti-HHV-6 activity and lower cytotoxicityP Wang, K Abe, T Ojima, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 1, 1989
[Radiation therapy of hepatocellular carcinoma]H Takagi, H Takayama, S Yamada, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Paraplegia|February 1, 1994
Prognosis of cervical spinal cord injury in correlation with magnetic resonance imagingT Sato, S Kokubun, K P Rijal, et al.
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|October 6, 2000
[Case-control study of risk factors for cedar pollinosis among parents of 3-year-old children]I Oki, S Tanihara, T Ojima, et al.
Archives of Virology|November 23, 2006
Analysis of hepatitis B surface antigen mutations in Mongolia: molecular epidemiology and implications for mass vaccinationD Davaalkham, T Ojima, R Uehara, et al.
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|January 22, 1998
[Development of index of social activities for the elderly]S Hashimoto, R Aoki, A Tamakoshi, et al.
Leukemia Research|July 10, 1999
Quantification of human herpesvirus 6 in healthy volunteers and patients with lymphoproliferative disorders by PCR-ELISAJ H Ohyashiki, K Abe, T Ojima, et al.
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|September 24, 1999
[Relationship between breast milk and atopic dermatitis in children]Y Nakamura, I Oki, S Tanihara, et al.
International Journal of Molecular Medicine|September 22, 2000
Use of real-time PCR to monitor human herpesvirus 6 reactivation after allogeneic bone marrow transplantationJ H Ohyashiki, A Suzuki, K Aritaki, et al.
Bone Marrow Transplantation|December 26, 2001
A rapid monitoring system of human herpesviruses reactivation by LightCycler in stem cell transplantationK Aritaki, J H Ohyashiki, A Suzuki, et al.
Microbiology and Immunology|August 11, 2001
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assays showed a lack of toxicity of ganciclovir (GCV), C.OXTs, and their derivatives, to TaY(OK) cells at 1 microM. Therefore we compared the antiviral potencies of these drugs at 1 microM by monitoring the viral loads produced during a 1-day period during the course of the drug treatment. Among the drugs tested, 3'-fluorocarbocyclic oxetanocin A (3'F-C.OXT-A) was the most effective for inhibiting the virus production, and at concentrations ranging from 0.5 microM to 10 microM, the inhibition of the viral production was dose-dependent. A comparison of the chemical structures of the derivatives with that of C.OXT-A, which is the parental molecule, suggested that the 3'-fluorine-modification might account for the higher anti-HHV-6 activity and lower cytotoxicityP Wang, K Abe, T Ojima, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 1, 1989
[Radiation therapy of hepatocellular carcinoma]H Takagi, H Takayama, S Yamada, et al.
Pageof 13